��������

Patrick Van Reijendam is currently the Head of Strategy and Operations for Global Product and Portfolio Strategy at Ipsen. They previously held the position of Director of International Launch Strategy, Planning & Execution at Intercept Pharmaceuticals from 2019 to 2021. Prior to that, Patrick worked at IMS Health as a Senior Consultant from 2010 to 2014 and also gained experience as a Business Insights & Future Portfolio Lead at AstraZeneca between 2017 and 2019. Patrick began their career as a Consultant at The Cornell Partnership from 2007 to 2010 and later contributed to Global Commercial Operations at Albireo Pharma, Inc. from 2021 to 2023.